Anxiogenesis in adult rats treated chronically with cocaine during adolescence: Effects of extended abstinence and 8-OH-DPAT treatment

Brain Research Bulletin

Volumn 76, Issue 4, 2008, Pages 402-411

  Santucci, Anthony C ^a   Madeira, Eva ^a  

^a MANHATTANVILLE COLLEGE   (United States)

Author keywords

5 HT1A; 8 OH DPAT; Anxiogenesis; Cocaine; Elevated zero maze; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; COCAINE;

ABSTINENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG EXPOSURE; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AGING; ANIMALS; ANXIETY DISORDERS; BRAIN; BRAIN CHEMISTRY; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 43849086333     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.02.023     Document Type: Article

References (87)

1. -/-) mice. Brain Res. 1071 (2006) 113-123
2. Aghajanian G.K., Sprouse J.S., and Rasmussen K. Physiology of the midbrain serotonin system. In: Meltzer H.Y. (Ed). Psychopharmacology: The Third Generation of Progress (1978), Raven Press, New York 141-149
3. American Psychological Association, Washington, DC, US. Ethical principles of psychologists and code of conduct. Am. Psychol. 57 (2002) 1060-1073
4. Anthony J.C., Tien A.Y., and Petronis K.R. Epidemiologic evidence on cocaine use and panic attacks. Am. J. Epidemiol. 129 (1989) 543-549
5. Baicy K., and London E.D. Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction 102 Suppl. 1 (2007) 5-15
6. Bauman A., and Phongsavan P. Epidemiology of substance use in adolescence: prevalence, trends and policy implications. Drug Alcohol Depend. 55 (1999) 187-207
7. Baumann M.H., and Rothman R.B. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Biol. Psychiatry 44 (1998) 578-591
8. Bertrand F., Lehmann O., Lazarus C., Jeltsch H., and Cassel J.C. Intraseptal infusions of 8-OH-DPAT in the rat impairs water-maze performances: effects on memory or anxiety?. Neurosci. Lett. 279 (2000) 45-48
9. Bishop S.J. Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn. Sci. 11 (2007) 307-316
10. Bonomo Y. Adolescent alcohol and other substance use: sharing the Australian experience. Ann. Acad. Med. Singapore 32 (2003) 29-35
11. Borowski T.B., and Kokkinidis L. The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis. Behav. Neurosci. 112 (1998) 952-965
12. Cao J., Lotfipour S., Loughlin S.E., and Leslie F.M. Adolescent maturation of cocaine-sensitive neural mechanisms. Neuropsychopharmacology 32 (2007) 2279-2289
13. Carey R.J., Damianopoulos E.N., and DePalma G. Differential temporal dynamics of serum and brain cocaine: relationship to behavioral, neuroendocrine and neurochemical cocaine induced responses. Life Sci. 55 (1994) 1711-1716
14. Carli M., and Samanin R. 8-Hydroxy-2-(di-N-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors. Br. J. Pharmacol. 105 (1992) 720-726
15. Carli M., Tatarczynska E., Cervo L., and Samanin R. Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur. J. Pharmacol. 234 (1993) 215-221
16. Carli M., Tranchina S., and Samanin R. 8-Hydroxy-2-(di-N-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task. Eur. J. Pharmacol. 211 (1992) 227-234
17. Caster J.M., Walker Q.D., and Kuhn C.M. A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence. Psychopharmacology (Berl.) 193 (2007) 247-260
18. Caster J.M., Walker Q.D., and Kuhn C.M. Enhanced behavioral response to repeated-dose cocaine in adolescent rats. Psychopharmacology (Berl.) 183 (2005) 218-225
19. Catlow B.J., and Kirstein C.L. Cocaine during adolescence enhances dopamine in response to a natural reinforcer. Neurotoxicol. Teratol. 29 (2007) 57-65
20. Choleris E., Thomas A.W., Kavaliers M., and Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 25 (2001) 235-260
21. Clark D.B., Kirisci L., and Tarter R.E. Adolescent versus adult onset and the development of substance use disorders in males. Drug Alcohol Depend. 49 (1998) 115-121
22. Collins S.L., and Izenwasser S. Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats. Brain Res. Dev. Brain Res. 138 (2002) 27-34
23. Cox B.J., Norton G.R., Swinson R.P., and Endler N.S. Substance abuse and panic-related anxiety: a critical review. Behav. Res. Ther. 28 (1990) 385-393
24. Cryan J.F., Kelly P.H., Chaperon F., Gentsch C., Mombereau C., Lingenhoehl K., et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J. Pharmacol. Exp. Ther. 310 (2004) 952-963
25. Cunningham K.A., Paris J.M., and Goeders N.E. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11 (1992) 112-123
26. Davis M. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol. Sci. 13 (1992) 35-41
27. De Vry J., Schreiber R., Melon C., Dalmus M., and Jentzsch K.R. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur. Neuropsychopharmacol. 14 (2004) 487-495
28. DeLeon K.R., Grimes J.M., Connor D.F., and Melloni Jr. R.H. Adolescent cocaine exposure and offensive aggression: involvement of serotonin neural signaling and innervation in male Syrian hamsters. Behav. Brain Res. 133 (2002) 211-220
29. Erb S., Kayyali H., and Romero K. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor. Pharmacol. Biochem. Behav. 85 (2006) 206-213
30. Estelles J., Lluch J., Rodriguez-Arias M., Aguilar M.A., and Minarro J. Cocaine exposure during adolescence affects anxiety in adult mice. Brain Res. Bull. 71 (2007) 393-403
31. Estroff T.W., Schwartz R.H., and Hoffmann N.G. Adolescent cocaine abuse. Addictive potential, behavioral and psychiatric effects. Clin. Pediatr. (Phila.) 28 (1989) 550-555
32. Fox H.C., Talih M., Malison R., Anderson G.M., Kreek M.J., and Sinha R. Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. Psychoneuroendocrinology 30 (2005) 880-891
33. Gallop R.J., Crits-Christoph P., Ten Have T.R., Barber J.P., Frank A., Griffin M.L., et al. Differential transitions between cocaine use and abstinence for men and women. J. Consult. Clin. Psychol. 75 (2007) 95-103
34. Gartside S.E., Ellis P.M., Sharp T., and Cowen P.J. Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Eur. J. Pharmacol. 221 (1992) 27-33
35. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 251 (1991) 1580-1586
36. Gawin F.H., and Ellinwood Jr. E.H. Cocaine dependence. Annu. Rev. Med. 40 (1989) 149-161
37. Gawin F.H., and Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch. Gen. Psychiatry 43 (1986) 107-113
38. Gordon M.K., and Rosen J.B. Lasting effect of repeated cocaine administration on acoustic and fear-potentiated startle in rats. Psychopharmacology (Berl.) 144 (1999) 1-7
39. Grossen N.E., and Kelley M.J. Species-specific behavior and acquisition of avoidance behavior in rats. J. Comp. Physiol. Psychol. 81 (1972) 307-310
40. Hayase T., Yamamoto Y., and Yamamoto K. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. Behav. Pharmacol. 16 (2005) 395-404
41. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15049-15054
42. Henningfield J.E., Cohen C., and Slade J.D. Is nicotine more addictive than cocaine?. Br. J. Addict. 86 (1991) 565-569
43. Huff N.C., and Rudy J.W. The amygdala modulates hippocampus-dependent context memory formation and stores cue-shock associations. Behav. Neurosci. 118 (2004) 53-62
44. Institute of Laboratory Animal Resources. Commission on Life Sciences, National Research Council, Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
45. Jacobson L.H., Bettler B., Kaupmann K., and Cryan J.F. Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. Psychopharmacology (Berl.) 190 (2007) 541-553
46. L.D. Johnston, P.M. O'Malley, J.G. Bachman, J.E. Schulenber, Monitoring the future national results on adolescent drug use: overview of key findings, 2006, NIH Publication No. 07-6202, National Institute on Drug Abuse, Bethesda, MD, 2006.
47. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 142 (1985) 1259-1264
48. Kienast T., and Heinz A. Dopamine and the diseased brain. CNS Neurol. Disord. Drug Targets 5 (2006) 109-131
49. Kile J.P., and Turner B.B. Serotonergic and cholinergic interaction in the regulation of pituitary-adrenal function in rats. Experientia 41 (1985) 1123-1127
50. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
51. Kulkarni S.K., Singh K., and Bishnoi M. Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. Methods Find Exp. Clin. Pharmacol. 29 (2007) 343-348
52. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 23 (2000) 155-184
53. Lee Y., Walker D., and Davis M. Lack of a temporal gradient of retrograde amnesia following NMDA-induced lesions of the basolateral amygdala assessed with the fear-potentiated startle paradigm. Behav. Neurosci. 110 (1996) 836-839
54. Levy A.D., Li Q., Alvarez Sanz M.C., Rittenhouse P.A., Brownfield M.S., and Van de Kar L.D. Repeated cocaine modifies the neuroendocrine responses to the 5-HT1C/5-HT2 receptor agonist DOI. Eur. J. Pharmacol. 221 (1992) 121-127
55. Levy A.D., Li Q.A., Kerr J.E., Rittenhouse P.A., Milonas G., Cabrera T.M., et al. Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. J. Pharmacol. Exp. Ther. 259 (1991) 495-500
56. Liang K.C. Pre- or post-training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5-HT1A receptors. Eur. J. Neurosci. 11 (1999) 1491-1500
57. Lopez-Aumatell R., Guitart-Masip M., Vicens-Costa E., Gimenez-Llort L., Valdar W., Johannesson M., et al. Fearfulness in a large N/Nih genetically heterogeneous rat stock: differential profiles of timidity and defensive flight in males and females. Behav. Brain Res. 188 (2008) 41-55
58. Lopez-Patino M.A., Yu L., Cabral H., and Zhdanova I.V. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol. Behav. 93 (2008) 160-171
59. Lu L., Liu D., and Ceng X. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur. J. Pharmacol. 415 (2001) 203-208
60. McGaugh J.L. Memory consolidation and the amygdala: a systems perspective. Trends Neurosci. 25 (2002) 456
61. Meert T.F. Ritanserin overcomes exploratory inhibition induced by cocaine withdrawal. Behav. Pharmacol. 3 (1992) 149-154
62. Micheau J., and Van Marrewijk B. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 23 (1999) 1113-1133
63. Mirza N.R., Nielsen E.O., and Troelsen K.B. Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 858-866
64. Perret G., Schluger J.H., Unterwald E.M., Kreuter J., Ho A., and Kreek M.J. Downregulation of 5-HT1A receptors in rat hypothalamus and dentate gyrus after "binge" pattern cocaine administration. Synapse 30 (1998) 166-171
65. Perrine S.A., Sheikh I.S., Nwaneshiudu C.A., Schroeder J.A., and Unterwald E.M. Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat. Neuropharmacology 54 (2008) 355-364
66. Porrino L.J., and Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb. Cortex 10 (2000) 326-333
67. Rebec G.V., and Sun W. Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. J. Exp. Anal. Behav. 84 (2005) 653-666
68. Reboussin B.A., and Anthony J.C. Is there epidemiological evidence to support the idea that a cocaine dependence syndrome emerges soon after onset of cocaine use?. Neuropsychopharmacology 31 (2006) 2055-2064
69. Revel L., Mennuni L., Garofalo P., and Makovec F. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity. Behav. Pharmacol. 9 (1998) 183-194
70. Rodgers R.J., Cao B.J., Dalvi A., and Holmes A. Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 30 (1997) 289-304
71. Rogerio R., and Takahashi R.N. Anxiogenic action of acute but not repeated cocaine administration in handling-habituated mice in the plus-maze test. Braz. J. Med. Biol. Res. 25 (1992) 713-716
72. Santucci A.C. Adolescent cocaine residually impairs working memory and enhances fear memory in rats. Exp. Clin. Psychopharmacol. 16 (2008) 77-85
73. Santucci A.C., Capodilupo S., Bernstein J., Gomez-Ramirez M., Milefsky R., and Mitchell H. Cocaine in adolescent rats produces residual memory impairments that are reversible with time. Neurotoxicol. Teratol. 26 (2004) 651-661
74. Santucci A.C., Cortes C., Bettica A., and Cortes F. Chronic ethanol consumption in rats produces residual increases in anxiety 4 months after withdrawal. Behav. Brain Res. 188 (2008) 24-31
75. A.C. Santucci, D. Rabidou, A. Rosario, Residual learning deficit and anxiogenesis in rats treated chronically with cocaine during adolescence, Society for Neuroscience Abstracts, Program No. 659.9, 2005.
76. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., and Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675 (1995) 89-97
77. Singh K.P., and Singh M. Effect of prenatal haloperidol exposure on behavioral alterations in rats. Neurotoxicol. Teratol. 24 (2002) 497-502
78. Sinha R., Fuse T., Aubin L.R., and O'Malley S.S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl.) 152 (2000) 140-148
79. Sinha R., Talih M., Malison R., Cooney N., Anderson G.M., and Kreek M.J. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl.) 170 (2003) 62-72
80. Smith R.F. Animal models of periadolescent substance abuse. Neurotoxicol. Teratol. 25 (2003) 291-301
81. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24 (2000) 417-463
82. Spear L.P., Silveri M.M., Casale M., Katovic N.M., Campbell J.O., and Douglas L.A. Cocaine and development: a retrospective perspective. Neurotoxicol. Teratol. 24 (2002) 321-327
83. Troelsen K.B., Nielsen E.O., and Mirza N.R. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. Psychopharmacology (Berl.) 181 (2005) 741-750
84. Valverde O., Mantamadiotis T., Torrecilla M., Ugedo L., Pineda J., Bleckmann S., et al. Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology 29 (2004) 1122-1133
85. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N.Y. Acad. Sci. 937 (2001) 1-26
86. Withers N.W., Pulvirenti L., Koob G.F., and Gillin J.C. Cocaine abuse and dependence. J. Clin. Psychopharmacol. 15 (1995) 63-78
87. Zernig G., Ahmed S.H., Cardinal R.N., Morgan D., Acquas E., Foltin R.W., et al. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 80 (2007) 65-119